Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 56,573 | 54,478 | 53,469 | 54,927 | 54,481 |
| Cost of Goods | 28,192 | 25,656 | 23,875 | 24,071 | 25,454 |
| Gross Profit | 28,381 | 28,822 | 29,594 | 30,856 | 29,027 |
| Operating Expenses | 32,157 | 31,455 | 29,531 | 27,592 | 27,980 |
| Operating Income | -3,584 | -1,977 | 938 | 3,335 | 1,501 |
| Interest Expense | 75 | 33 | 64 | 22 | 33 |
| Other Income | -149 | 8 | 7 | 44 | 102 |
| Pre-tax Income | -3,808 | -2,002 | 881 | 3,357 | 1,570 |
| Income Tax | 694 | 534 | 629 | 686 | 635 |
| Net Income Continuous | -4,502 | -2,536 | 252 | 2,671 | 935 |
| Net Income | $-4,502 | $-2,536 | $252 | $2,671 | $935 |
| EPS Basic Total Ops | -0.11 | -0.06 | 0.01 | 0.08 | 0.02 |
| EPS Basic Continuous Ops | -0.11 | -0.06 | 0.01 | 0.07 | 0.02 |
| EPS Diluted Total Ops | -0.11 | -0.06 | 0.01 | 0.07 | 0.02 |
| EPS Diluted Continuous Ops | -0.11 | -0.06 | 0.01 | 0.07 | 0.02 |
| EPS Diluted Before Non-Recurring Items | -0.06 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-891 | $593 | $3,134 | $5,829 | $3,945 |